Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 ...

The released batch was manufactured at Everest's Jiashan manufacturing site using the Company's proprietary mRNA platform, in compliance with global GMP standards. EVM14 is an off-the-shelf ...

A study in Chemistry A European Journal reveals that reduced MUC1 antigen density on gold nanoparticles still elicits potent ...

We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...

Quanyin Hu, a professor in the UW-Madison School of Pharmacy, said the approach could theoretically be applied to any cancer ...

While research in mice has shown encouraging results, the next phases of human trials will need to confirm safety and ...

Pancreatic cancer is one of the deadliest diseases known to medicine. It’s hard to detect, quick to spread, and resistant to most treatments. With a five-year survival rate of just 13%, pancreatic ...

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer ...

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing ...

Research in mice shows that the vaccine has been successful in activating the immune system against alpha-lactalbumin and ...

A vaccine that could help fight one of the deadliest forms of cancer is in the works - and could one day become a reality.

US researchers have found that developing personalised vaccines can play a key role in keeping aggressive tumours from ...